Daftar pustaka

1. European Society of Cardiology. 2016 ESC Guidelines for the diagnosis and
treatment of acute and chronic heart failure.European Heart Journal (2016) 37, 2129–
2200
2. Wang TJ. Natural history of asymptomatic left ventricular systolic dysfunction in the
community. Circulation 2003;108:977– 982.
3. The SOLVD Investigators. Effect of enalapril on mortality and the development of
heart failure in asymptomatic patients with reduced left ventricular ejection fractions.
N Engl J Med 1992;327:685– 691.
4. RuttenFH,MoonsKGM,CramerM-JM, Grobbee DE, Zuithoff NPA,Lammers J-WJ,
Hoes AW. Recognising heart failure in elderly patients with stable chronic obstructive
pulmonary disease in primary care: cross sectional diagnostic study. BMJ
2005;331:1379.
5. Hawkins NM, Petrie MC, Jhund PS, Chalmers GW, Dunn FG, McMurray JJV. Heart
failure and chronic obstructive pulmonary disease: diagnostic pitfalls and
epidemiology. Eur J Heart Fail 2009;11:130– 139.
6. Daniels LB, Clopton P, Bhalla V, Krishnaswamy P, Nowak RM, McCord J,
Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AHB, Steg PG,
Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC,McCullough PA,
Maisel AS. How obesity affects the cut-points for B-type natriuretic peptide in the
diagnosis of acute heart failure. Results from the Breathing Not Properly
Multinational Study. Am Heart J 2006;151:999– 1005.
7. Badan Penelitian dan Pengembangan Kesehatan Kementerian Kesehatan RI. Riset
Kesehatan Dasar 2013. di unduh dari
http://www.depkes.go.id/resources/download/general/Hasil%20Riskesdas%202013
8. Kabo,Peter.Bagaimana Menggunakan Obat-Obat Kardiovaskular Secara
Rasional.Jakarta: Balai Penerbit Fakultas Kedokteran Universitas Indonesia; 2012
9. Fuster V, Walsh RA, O'Rourke RA, Poole-Wilson P. Pathophysiology of Heart
Failure.Hurst's The Heart 13th Ed : McGraw Hill; 2011: 719
10. Lilly Ls. Pathophysiology of heart disease. Baltimore: Lippincott Williams
Wilkins fifth edition; 2011. p. 228
11. Braunwald’s heart disease : a textbook of cardiovascular medicine / edited by Douglas
L. Mann,Douglas P. Zipes, Peter Libby, Robert O. Bonow, Eugene Braunwald.—10th
edition. Elsavier; 2015
12. Fauci AS, Kasper DL, Longo D, Braunwald E, Hauser SL, Loscalzo J, et al.
Harrison's Principles of Internal Medicine, 17th Edition. United States of America:
Mcgraw-hil; 2008: 1901
13. Weber KT: Aldosterone in congestive heart failure. N Engl J Med 345:1689, 2001;
and Weber KT, Villareal D: Aldosterone and antialdosterone therapy in congestive
heart failure. Am J Cardiol 71[suppl 3A]:11A, 1993
14. Colucci WS [ed]:Atlas of Heart Failure. 4th ed. Philadelphia, Current Medicine LLC,
2008, p 107.
15. Fuster V, Walsh RA, O'Rourke RA, Poole-Wilson P. Pathophysiology of Heart
Failure. Hurst's The Heart 13th Ed : McGraw Hill; 2011: 721
16. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and
management of chronic heart failure in the adult: executive summary. Circulation.
2001;104:2996–3007.
17. Perhimpunan Dokter Spesialis Kardiovaskular Indonesia. Pedoman Tatalaksana Gagal
Jantung. Edisi Pertama; 2015
18. McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL,
Shi VC, Solomon SD, Swedberg K, Zile MR, PARADIGM-HF Investigators and
Committees. Angiotensin-neprilysin inhibition versus enalapril in heart failure. NEngl
J Med 2014;371:993–1004.